GM plants differ from non-GM parents in unintended ways – and that goes for GM gene-edited plants too
By Staff,
GMWatch
| 03. 28. 2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important question, we thought it would be worth exploring the evidence for how GM plants differ from conventional ones.
First-generation GMOs
There is good evidence of unintended changes between older-style, first-generation (“transgenic” – involving random insertion of foreign gene(s)) genetically modified organisms (GMOs) and their non-GMO counterparts. For example, a review of “omics" molecular profiling studies by Benevenuto et al (2022) concluded: “Several altered metabolic pathways have been found in the comparative omics studies assessing unintended effects in GM crops.”
This review includes the work of Prof Michael Antoniou and colleagues on glyphosate-tolerant NK603 GM maize vs its non-GM isogenic (with the same genetic background, but without genetic modification) parent. This study found that there were major protein and biochemical (metabolite) differences between the GM and non-GM maize and that these differences were due to the GM transformation process, leading the...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...